Fatigue level changes with time in long-term Hodgkin and non-Hodgkin lymphoma survivors: a joint EORTC-LYSA cross-sectional study.

Raphaël BussonMarleen van der KaaijNicolas MounierBerthe M P AlemanCatherine ThiéblemontAspasia StamatoullasVincent RibragHervé TillyCorinne HaiounRené-Olivier CasasnovasHanneke C Kluin-NelemansMichel Henry-Amar

Published in: Health and quality of life outcomes (2019)

Among lymphoma survivors progressive increase of fatigue level with time since treatment completion is a distinctive feature of HL. Our data suggest that changes in fatigue level are unlikely to only depend on treatment complications and health disorders. Investigations should be undertaken to identify which factors including biologic mechanisms could explain why a substantial proportion of survivors develop high level of fatigue.

Keyphrases

young adults
sleep quality
healthcare
public health
rheumatoid arthritis
multiple sclerosis
machine learning
risk factors
deep learning
diffuse large b cell lymphoma
big data
social media
electronic health record
health information
climate change
hodgkin lymphoma
replacement therapy